Source: BrainStorm Cell Therapeutics Inc.
Date: July 7, 2008
Summary:
In an official company news release, BrainStorm Cell Therapeutics Inc., a biotechnology company in the field of adult stem cell research, announced the completion of a preclinical study to treat spinal cord injuries in animals using adult neural stem cells:
" BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, has completed a preclinical study in collaboration with the W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The study conducted at the Keck Center was an effort to repair spinal cord injuries in animals through the transplantation of Brainstorm’s neurotrophic factor (NTF) adult stem cells. The results showed a positive trend of the NTF cells in the male animals."
